| 摘要 |
The presently disclosed subject matter relates to cytoplasmic, Fc region, and nuclear antibody compositions and methods of use thereof, particularly wherein the compositions are used as an enrichment product for intravenous immunoglobulins. More particularly, the presently disclosed subject matter relates to methods of use of the disclosed compositions for treating or diagnosing blood related cancers, immune complex-mediated diseases, and certain autoimmune disorders. |
